{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:50:46Z","timestamp":1785876646551,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jaad.2007.10.645","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T07:53:39Z","timestamp":1203062019000},"page":"395-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Subcutaneous efalizumab is not effective in the treatment of alopecia areata"],"prefix":"10.1016","volume":"58","author":[{"given":"Vera H.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Hordinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse S.","family":"Rafal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Altrabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin R.","family":"Garovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivor","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.10.645_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1067\/mjd.2000.103909","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2230.2002.01077.x","article-title":"Epidemiology and genetics of alopecia areata","volume":"27","author":"McDonagh","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2007.10.645_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1529-8019.2001.01036.x","article-title":"Clinical presentations of alopecia areata","volume":"14","author":"Hordinsky","year":"2001","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2007.10.645_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archderm.139.12.1555","article-title":"Histopathologic features of alopecia areata: a new look","volume":"139","author":"Whiting","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1087-0024.2003.00802.x","article-title":"Alopecia areata: autoimmunity\u2014the evidence is compelling","volume":"8","author":"Kalish","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2007.10.645_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archderm.138.7.916","article-title":"Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice","volume":"138","author":"Gilhar","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1087-0024.2004.00835.x","article-title":"Autoimmunity: alopecia areata","volume":"9","author":"Hordinsky","year":"2004","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2007.10.645_bib9","first-page":"1007","article-title":"Alopecia in women","volume":"67","author":"Thiedke","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2007.10.645_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1087-0024.2003.00811.x","article-title":"Therapy of alopecia areata: on the cusp and in the future","volume":"8","author":"Price","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2007.10.645_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1747.2003.12165.x","article-title":"Alopecia areata: treatment of today and tomorrow","volume":"8","author":"Freyschmidt-Paul","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2007.10.645_bib12","first-page":"3","article-title":"DPCP for the treatment of alopecia areata","volume":"5","author":"Bolduc","year":"2000","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jaad.2007.10.645_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/120347540500900606","article-title":"Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled phase III trials: part I","volume":"9","author":"Pariser","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2007.10.645_bib15","series-title":"Raptiva (efalizumab)","author":"Genentech","year":"2004"},{"key":"10.1016\/j.jaad.2007.10.645_bib16","first-page":"202","article-title":"Dermatology quality of life scales\u2014a measure of the impact of skin diseases","volume":"136","author":"Morgan","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2006.05.062","article-title":"Treatment of alopecia areata partim universalis with efalizumab","volume":"55","author":"Kaelin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0091270004270260","article-title":"Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis","volume":"45","author":"Mortensen","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2007.10.645_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000077660","article-title":"T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action","volume":"208","author":"Jullien","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.10.645_bib21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.141.12.1513","article-title":"Alefacept for alopecia areata","volume":"141","author":"Heffernan","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1540-9740.2006.05443.x","article-title":"Failure of two TNF-alpha blockers to influence the course of alopecia areata","volume":"5","author":"Abramovits","year":"2006","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2007.10.645_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.10.645_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.141.6.759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","volume":"141","author":"Posten","year":"2005","journal-title":"Arch Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207022840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207022840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:11:35Z","timestamp":1759270295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207022840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0190962207022840"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.10.645","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.10.645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}